Nicotin Al (Nicotine)

Nicotine in Nicotin Al acts as an agonist at neuronal nicotinic acetylcholine receptors, especially the α4β2 subtype. Stimulation of these receptors leads to the release of dopamine and other neurotransmitters, which eases the discomfort of nicotine withdrawal and diminishes cravings, thereby supporting the quitting process.

The specific dose and dosing schedule of Nicotin Al are determined by the prescribing healthcare professional based on the individual’s smoking history, dependence level, and overall health. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for Nicotin Al in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used if the potential benefits justify the possible risks to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To order Nicotin Al, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details, and any necessary import documentation.

Nicotin Al provides nicotine replacement, whereas alternatives such as varenicline act as partial agonists at the same receptors, and bupropion works through norepinephrine and dopamine reuptake inhibition. Nicotine replacement can be easier to titrate and may have fewer neuropsychiatric concerns, while varenicline and bupropion offer non‑nicotine mechanisms that some patients prefer.

Nicotin Al should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture, excessive heat, and direct sunlight. Ensure the container is tightly closed to maintain product stability throughout its shelf life.

Nicotin Al is administered orally. The exact form (tablet, lozenge, or other oral dosage) is determined by the manufacturer’s specification. Patients should take the medication exactly as prescribed, usually with water, and follow any specific instructions regarding timing relative to meals or other medications.

Serious risks include cardiovascular events such as hypertension or arrhythmia, severe allergic reactions (anaphylaxis), seizures, respiratory depression, and persistent vomiting. Patients should seek immediate medical attention if they experience symptoms like chest pain, difficulty breathing, swelling of the face or throat, or uncontrolled seizures.

Nicotin Al should be avoided in individuals with known hypersensitivity to nicotine or any of the product’s excipients. It is also contraindicated in patients with recent myocardial infarction, uncontrolled hypertension, or severe cardiovascular disease without careful medical supervision. Pregnant or breastfeeding women should only use it if a healthcare professional determines that the benefits outweigh the risks.